Standardized bleeding definitions after transbronchial lung biopsy: a Delphi consensus statement from the Nashville Working Group.

MedStar author(s):
Citation: Chest. 2020 Feb 14PMID: 32067944Institution: MedStar Franklin Square Medical CenterDepartment: Angelos Center for Lung DiseaseForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2020ISSN:
  • 0012-3692
Name of journal: ChestAbstract: BACKGROUND: Transbronchial lung biopsies are commonly performed for a variety of indications. While generally well tolerated, complications such as bleeding do occur. Description of bleeding severity is crucial both clinically and in research trials; to date, there is no validated scale that is widely accepted for; this purpose.RESEARCH QUESTION: Can a simple, reproducible tool for categorizing the severity of bleeding after transbronchial biopsy be created?RESULTS: Thirty-six expert bronchoscopists from eight countries, both in academic and community practice settings, participated in creation of the scale. After the live meeting, two iterations were made. The second and final scale was vetted by all 36 participants, with a weighted average of 4.47/5; 53% were satisfied, and 47% were very satisfied. The panel reached a consensus and propose the Nashville Bleeding Scale. Copyright (c) 2020. Published by Elsevier Inc.STUDY DESIGN: and Methods: Using the modified Delphi method, an international group of bronchoscopists sought to create a new scale tailored to assess bleeding severity for patients undergoing flexible bronchoscopy with transbronchial lung biopsies. Cessation criteria were specified a priori and included reaching >80% consensus among the experts or three rounds, whichever occurred first.All authors: Aragaki-Nakahodo AA, Bansal S, Barisione E, Benzaquen S, Bowling MR, Christensen M, Fernandez-Bussy S, Flandes J, Folch EE, Herth F, Hinze JD, Kazakov J, Keyes C, Khandhar SJ, Kinsey CM, Krimsky WS, Krishna G, Labarca G, Lau K, LeMense GP, Lentz RJ, Lutz PO, Mahajan AK, Majid A, Maldonado F, Mehta AC, Nead MA, Oberg CL, Oh S, Parks C, Perret K, Salio M, Studnicka M, Teba CV, Toloza E, Waller E, Zanchi D, Zgoda MFiscal year: FY2020Digital Object Identifier: Date added to catalog: 2020-02-26
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32067944 Available 32067944

BACKGROUND: Transbronchial lung biopsies are commonly performed for a variety of indications. While generally well tolerated, complications such as bleeding do occur. Description of bleeding severity is crucial both clinically and in research trials; to date, there is no validated scale that is widely accepted for; this purpose.

RESEARCH QUESTION: Can a simple, reproducible tool for categorizing the severity of bleeding after transbronchial biopsy be created?

RESULTS: Thirty-six expert bronchoscopists from eight countries, both in academic and community practice settings, participated in creation of the scale. After the live meeting, two iterations were made. The second and final scale was vetted by all 36 participants, with a weighted average of 4.47/5; 53% were satisfied, and 47% were very satisfied. The panel reached a consensus and propose the Nashville Bleeding Scale. Copyright (c) 2020. Published by Elsevier Inc.

STUDY DESIGN: and Methods: Using the modified Delphi method, an international group of bronchoscopists sought to create a new scale tailored to assess bleeding severity for patients undergoing flexible bronchoscopy with transbronchial lung biopsies. Cessation criteria were specified a priori and included reaching >80% consensus among the experts or three rounds, whichever occurred first.

English

Powered by Koha